Oseltamivir
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Oseltamivir and local guidelines before prescribing.
Neuraminidase inhibitor
Mechanism
Neuraminidase inhibitor preventing viral release.
Uses
Influenza treatment and prophylaxis.
Dosing
- Oseltamivir Influenza | 75 mg twice daily for 5 days (adjust for renal function); for at-risk patients and all hospital admissions with suspected influenza in season.
Respiratory: Infections
Side effects
Nausea, vomiting, headache, neuropsychiatric events rare.
Interactions
Few; probenecid raises levels.
Contraindications and cautions
Hypersensitivity
Monitoring
Renal function
Pregnancy and breastfeeding
Use if indicated
Renal and hepatic impairment
Reduce dose if CrCl below 60
Overdose and reversal
Supportive
Special advice
Start within 48 hours of symptoms in at-risk patients; adjust for renal function.
More from the textbook: uses, cautions and other points
- Antivirals - oseltamivir for influenza in at-risk people (within 48 hours); COVID-19 antivirals in eligible high-risk patients.
Respiratory: Anatomy, Physiology and Pharmacology - Influenza in season: Antivirals (e.g. oseltamivir) for hospitalised patients.
Respiratory: Emergencies - Influenza - oseltamivir (oral) within 48 hours of symptoms for people at risk of complications, all hospitalised patients with suspected influenza, and as post-exposure prophylaxis in at-risk groups when flu is circulating (NICE); zanamivir (inhaled - bronchospasm; IV for resistant or severe cases).
ID: How Infection Happens - Oseltamivir | Influenza within 48 hours in at-risk and hospitalised patients.
ID: How Infection Happens - Treatment - oseltamivir (5 days) for at-risk people with influenza-like illness when flu is circulating, ideally within 48 hours of symptoms, and for all hospitalised patients with suspected influenza (even later); zanamivir for resistance or severe illness; treat bacterial complications.
ID: Viral, fungal and parasitic infections - Oseltamivir | Influenza - at-risk within 48 hours, all hospitalised; prophylaxis in outbreaks.
ID: Viral, fungal and parasitic infections
Where it is discussed in the book
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Respiratory: Emergencies (1 mention)
- Respiratory: Infections (1 mention)
- ID: How Infection Happens (2 mentions)
- ID: Viral, fungal and parasitic infections (3 mentions)
- Integrated respiratory chapter (2 mentions)
- Microbiology: Virology - structure, replication and important viral infections (3 mentions)